» Articles » PMID: 17239419

Changes in the V3 Region of Gp120 Contribute to Unusually Broad Coreceptor Usage of an HIV-1 Isolate from a CCR5 Delta32 Heterozygote

Abstract

Heterozygosity for the CCR5 Delta32 allele is associated with delayed progression to AIDS in human immunodeficiency virus type 1 (HIV-1) infection. Here we describe an unusual HIV-1 isolate from the blood of an asymptomatic individual who was heterozygous for the CCR5 Delta32 allele and had reduced levels of CCR5 expression. The primary virus used CCR5, CXCR4, and an unusually broad range of alternative coreceptors to enter transfected cells. However, only CXCR4 and CCR5 were used to enter primary T cells and monocyte-derived macrophages, respectively. Full-length Env clones had an unusually long V1/V2 region and rare amino acid variants in the V3 and C4 regions. Mutagenesis studies and structural models suggested that Y308, D321, and to a lesser extent K442 and E444, contribute to the broad coreceptor usage of these Envs, whereas I317 is likely to be a compensatory change. Furthermore, database analysis suggests that covariation can occur at positions 308/317 and 308/321 in vivo. Y308 and D321 reduced dependence on the extracellular loop 2 (ECL2) region of CCR5, while these residues along with Y330, K442, and E444 enhanced dependence on the CCR5 N-terminus compared to clade B consensus residues at these positions. These results suggest that expanded coreceptor usage of HIV-1 can occur in some individuals without rapid progression to AIDS as a consequence of changes in the V3 region that reduce dependence on the ECL2 region of CCR5 by enhancing interactions with conserved structural elements in G-protein-coupled receptors.

Citing Articles

The impact of genetic adaptation on chimpanzee subspecies differentiation.

Schmidt J, de Manuel M, Marques-Bonet T, Castellano S, Andres A PLoS Genet. 2019; 15(11):e1008485.

PMID: 31765391 PMC: 6901233. DOI: 10.1371/journal.pgen.1008485.


Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.

Beauparlant D, Rusert P, Magnus C, Kadelka C, Weber J, Uhr T PLoS Pathog. 2017; 13(3):e1006255.

PMID: 28264054 PMC: 5354460. DOI: 10.1371/journal.ppat.1006255.


Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Woodham A, Skeate J, Sanna A, Taylor J, Da Silva D, Cannon P AIDS Patient Care STDS. 2016; 30(7):291-306.

PMID: 27410493 PMC: 4948215. DOI: 10.1089/apc.2016.0100.


Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor.

Jiang X, Feyertag F, Meehan C, McCormack G, Travers S, Craig C J Virol. 2015; 89(22):11457-72.

PMID: 26339063 PMC: 4645647. DOI: 10.1128/JVI.01384-15.


Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.

Henrich T, Hanhauser E, Hu Z, Stellbrink H, Noah C, Martin J AIDS. 2015; 29(8):867-76.

PMID: 25730507 PMC: 4473772. DOI: 10.1097/QAD.0000000000000629.


References
1.
Burton D, Pyati J, Koduri R, Sharp S, Thornton G, Parren P . Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science. 1994; 266(5187):1024-7. DOI: 10.1126/science.7973652. View

2.
Kirchhoff F, Greenough T, Brettler D, Sullivan J, Desrosiers R . Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med. 1995; 332(4):228-32. DOI: 10.1056/NEJM199501263320405. View

3.
Trkola A, Pomales A, Yuan H, Korber B, Maddon P, Allaway G . Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol. 1995; 69(11):6609-17. PMC: 189569. DOI: 10.1128/JVI.69.11.6609-6617.1995. View

4.
Deacon N, Tsykin A, Solomon A, Smith K, Hooker D, McPhee D . Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 1995; 270(5238):988-91. DOI: 10.1126/science.270.5238.988. View

5.
Allaway G, Beaudry G, Garcia E, Wong E, Ryder A, Hasel K . Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates. AIDS Res Hum Retroviruses. 1995; 11(5):533-9. DOI: 10.1089/aid.1995.11.533. View